Postoperative radiotherapy for endometrial cancer |
Choi, Eun Cheol
(Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine)
Kim, Jin Hee (Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine) Kim, Ok Bae (Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine) Byun, Sang Jun (Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine) Park, Seung Gyu (Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine) Kwon, Sang Hoon (Department of Gynecology and Obstetrics, Dongsan Medical Center, Keimyung University School of Medicine) |
1 | Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108:226-33. DOI ScienceOn |
2 | Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 2006;103:155-9. DOI ScienceOn |
3 |
Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT) |
4 | US National Institute of Health. ClinicalTrials.gov [Internet]. Bethesda, MD: US National Institute of Health; c2012 [cited 2012 Sep 15]. Available from: http://clinicaltrials.gov/ct2/ home. |
5 | Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 1998;70:247-54. DOI ScienceOn |
6 | Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res 2008;34:776-83. DOI ScienceOn |
7 | Yalman D, Ozsaran Z, Anacak Y, et al. Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases. Eur J Gynaecol Oncol 2000;21:311-5. |
8 | Yoney A, Yildirim C, Bati Y, Unsal M. Low risk stage I endometrial carcinoma: prognostic factors and outcomes. Indian J Cancer 2011;48:204-10. DOI ScienceOn |
9 | Pessini SA, Zettler CG, Wender MC, Pellanda LC, Silveira GP. Survival and prognostic factors of patients treated for stage I to stage III endometrial carcinoma in a reference cancer center in Southern Brazil. Eur J Gynaecol Oncol 2007;28:48-50. |
10 | Li J, Kong WM. Prognostic factors of stage III endometrial carcinoma. Zhonghua Yi Xue Za Zhi 2009;89:198-200. |
11 | Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973;36:207-14. DOI |
12 | Trabert B, Wentzensen N, Yang HP, et al. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 2012 May 3 [Epub]. http://dx.doi.org/10.1002/ijc.27623. |
13 | National Cancer Information Center (Korea). Cancer incidence [Internet]. Goyang (KR): National Cancer Information Center; c2011 [cited 2012 Sep 15]. Available from: http://www.cancer.go.kr/ncic/cics_f/01/011/index.html. |
14 | Lee CM, Szabo A, Shrieve DC, et al. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study. Cancer 2007;110:2092-100. DOI ScienceOn |
15 | ASTEC/EN.5 Study Group, Blake P, Swart AM, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:137-46. DOI ScienceOn |
16 | Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11. DOI ScienceOn |
17 | Scotti V, Borghesi S, Meattini I, et al. Postoperative radiotherapy in stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence. Int J Gynecol Cancer 2010;20:1540-8. |
18 | Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: longterm outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 2005;63:834-8. DOI ScienceOn |
19 | Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51. DOI ScienceOn |
20 | Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-27. |
21 | Eiriksson L, Cuartero J, Steed H, et al. Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only. Int J Gynecol Cancer 2010;20:1356-62. |
22 | Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006;24:36-44. DOI ScienceOn |
23 | Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006;95:266-71. DOI ScienceOn |
![]() |